nab-Paclitaxel (Abraxane®): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors

被引：0
|
作者：
J Iglesias
机构：
[1] Abraxis Bioscience,
来源：
Breast Cancer Research | / 11卷
关键词：
Paclitaxel; Docetaxel; Metastatic Breast Cancer; Taxanes; Polysorbate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel
    Vigata, Margaux
    Meinert, Christoph
    Pahoff, Stephen
    Bock, Nathalie
    Hutmacher, Dietmar W.
    POLYMERS, 2020, 12 (02)
  • [32] Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
    Thomas E. Stinchcombe
    Mark A. Socinski
    Christine M. Walko
    Bert H. O’Neil
    Frances A. Collichio
    Anastasia Ivanova
    Hua Mu
    Michael J. Hawkins
    Richard M. Goldberg
    Celeste Lindley
    E. Claire Dees
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 759 - 766
  • [33] Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    Walko, Christine M.
    O'Neil, Bert H.
    Collichio, Frances A.
    Ivanova, Anastasia
    Mu, Hua
    Hawkins, Michael J.
    Goldberg, Richard M.
    Lindley, Celeste
    Dees, E. Claire
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 759 - 766
  • [34] Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: A clinical review
    Chirgwin, J.
    Chua, S. L.
    BREAST, 2011, 20 (05): : 394 - 406
  • [35] Phase II trial of nab-paclitaxel (nanoparticle albumin-bound paclitaxel (ABX)) plus capecitabine (XEL) in first-line treatment of metastatic breast cancer (MBC)
    Somer, B. G.
    Schwartzberg, L. S.
    Arena, F.
    Epperson, A.
    Fu, D.
    Fortner, B. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Saxena, Ashish
    Schneider, Bryan J.
    Christos, Paul J.
    Audibert, Lauren F.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    MEDICAL ONCOLOGY, 2016, 33 (02) : 1 - 9
  • [37] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Ashish Saxena
    Bryan J. Schneider
    Paul J. Christos
    Lauren F. Audibert
    Jennifer M. Cagney
    Ronald J. Scheff
    Medical Oncology, 2016, 33
  • [38] A phase I dose escalation study of a 2 day lapatinib chemosensitization pulse preceding weekly intravenous nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in patients with advanced cancer
    Chien, A. J.
    Illi, J. A.
    Ko, A. H.
    Dubey, S.
    Jahan, T. M.
    Hylton, N. M.
    Yeh, B. M.
    Huang, Y.
    Koch, K. M.
    Moasser, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Treatment innovations for metastatic breast cancer: Nanopartiele albumin-bound (NAB) technology targeted to tumors
    Lluch, Ana
    Alvarez, Isabel
    Munoz, Montserrat
    Angel Segui, Miguel
    Tusquets, Ignasi
    Garcia-Estevez, Laura
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (01) : 62 - 72
  • [40] Nanoparticle Albumin-Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
    Fu, Qiang
    Sun, Jin
    Zhang, Wenping
    Sui, Xiaofan
    Yan, Zhongtian
    He, Zhonggui
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (03) : 262 - 272
12345